Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Institute of Human Virology announces grants and new international center to tackle HIV/AIDS

Nov. 24, 2016

Yisheng Biopharma to collaborate with The Scripps Research Institute in developing new AIDS vaccine

Nov. 15, 2016

VRC-01 only slightly delays HIV rebound in clinical studies

Nov. 11, 2016

TaiMed Biologics notifies Theratechnologies of preliminary results for phase III trial of ibalizumab

Nov. 11, 2016

ViiV Healthcare UK discloses antiviral agents

Nov. 10, 2016

Anti-alpha4beta7 MAb regimen leads to SIV suppression long after treatment in monkeys

Nov. 2, 2016

Gilead Sciences develops HIV integrase inhibitors

Oct. 26, 2016

Merck & Co. patents HIV integrase inhibitors

Oct. 11, 2016

Gilead opens phase II/III study of fixed-dose combination in young patients with HIV-1 infection

Oct. 7, 2016

Selexis expands collaboration with IAVI

Sep. 23, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...